Todd Franklin Watanabe - 05 May 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
President and CEO, Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Todd Franklin Watanabe
Issuer symbol
ARQT
Transactions as of
05 May 2022
Transactions value $
-$21,760
Form type
4
Filing time
05 May 2022, 17:31:56 UTC
Previous filing
05 Apr 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale -$21.8K -1K -0.15% $21.76 659K 05 May 2022 Direct F1, F2
holding ARQT Common Stock 57.4K 05 May 2022 By LLC F3
holding ARQT Common Stock 17.9K 05 May 2022 By Trust F4
holding ARQT Common Stock 17.9K 05 May 2022 By Trust F5
holding ARQT Common Stock 125K 05 May 2022 By Trust F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 Includes 109,925 restricted stock units.
F3 The securities are held of record by Watanabe Ventures, LLC, of which the Reporting Person is the Chief Operating Officer. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F4 The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F5 The securities are held of record by The John Franklin Watanabe Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
F6 The securities are held of record by The Watanabe 2016 Irrevocable Trust, of which the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.